Skip to main content

Small Molecule Drug Discovery

Guiding the way to accelerate drug discovery

With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow. As a strategic partner, Revvity's goal is to support these workflows by its superior offering of drug discovery technologies, ranging from instruments, reagents, data analysis and bioinformatics tools for drug discovery to first-class customer service and support. Revvity works with the customer to enable deeper biological disease understanding and support the application of novel innovative technologies to address unmet medical needs and provide evidence for target engagement. Discover how Revvity can support your research from DNA/RNA- to protein/cell-based solutions.

  • Streamlined target selection with cutting-edge technologies.
  • Advanced lead discovery platforms to accelerate compound identification.
  • Comprehensive lead optimization strategies for higher efficacy and safety.
  • Integrated drug screening platforms for efficient throughput. 


For research use only. Not for use in diagnostic procedures.

How to interrogate biology

The discovery of new targets for drug development requires a deep understanding of the intricate biological mechanisms underlying disease. This understanding is typically achieved by studying the molecular biology of cells and tissues through various biological assays.

Learn more

The discovery of new targets for drug development requires a deep understanding of the intricate biological mechanisms underlying disease. This understanding is typically achieved by studying the molecular biology of cells and tissues through various biological assays.

Learn more

How to detect and measure

Obtaining the most relevant and robust data from cells and model systems necessitates the right combination of assays and. Selecting the wrong instrumentation can significantly impact the accuracy and efficiency of your drug development workflow.

Learn more

Obtaining the most relevant and robust data from cells and model systems necessitates the right combination of assays and. Selecting the wrong instrumentation can significantly impact the accuracy and efficiency of your drug development workflow.

Learn more

How to automate and analyze

From cellular screening and imaging applications to high-throughput screening and genomics-based applications, our integrated systems will help simplify your handling and detection needs, saving you time and improving efficiencies.

Learn more

From cellular screening and imaging applications to high-throughput screening and genomics-based applications, our integrated systems will help simplify your handling and detection needs, saving you time and improving efficiencies.

Learn more

Target Selection
Identify and Validate Your Disease-Relevant Targets For Unmet Medical Needs:

Selecting the right target remains one of the most important decisions and investments that companies make in the drug discovery process. Pursuing the wrong target can waste significant amounts of time and money, and eventually result in failure of the program. To ensure downstream success, targets must be accurately identified and thoroughly validated by demonstrating a strong link between target and disease with differentiated efficacy alongside available and predictive biomarkers.

When combined, our in vitro and in vivo technologies provide data on the biological entity associated with disease of interest and if appropriate modulation of target anticipated impacts disease in a consistent manner to make the most accurate prediction of target relevance in human disease. 
 

Lead Discovery
Find Your Hits for Disease-Relevant Targets: 

Once a target has been selected, the next stage of the drug discovery process involves developing biologically-relevant assays to identify active molecules in biochemical and/or cell-based assays. To maximize the hit finding probability, multiple screening techniques are required to engage and confirm findings orthogonally.

Revvity’s screening solutions can help you identify and confirm your drug compounds quickly and efficiently to advance it to the next stage. With our reliable and validated screening assays, multimode plate readers, state-of-the-art imaging high-content instruments, integrated automation for liquid handling, and powerful analysis software, our portfolio brings consistent, accurate, physiologically relevant results for faster discoveries and impactful breakthroughs to gain more confidence in your discovery. 
 

Lead Optimization
Optimize Your Lead Series for Highly Validated Targets:

Moving hits into highly quality lead series is the main goal of lead optimization to gain the broadest possible chemical insight. In this phase, analogs of leads are prepared and synthesized to improve biological properties for clinical development. Earlier toxicity studies eliminates the risk of molecular-related safety issues as a cause of project closure. Improvements are critical and sometimes challenging for novel, demanding but highly validated targets.

With our validated screening assays and multimode plate readers, state-of-the-art imaging instruments for High Content as well as In Vivo, integrated automation for liquid handling, and powerful analysis software, our portfolio brings consistent, accurate, physiologically relevant results for faster discoveries and impactful breakthroughs to gain more confidence in your discovery. 
 

Questions?
We’re here to help.

Contact us

Please note that product labeling (such as kit insert, product label, and kit box) may be different compared to the company branding. Please contact your local representative for further details.